PDCD1LG2 and neoplasm: Since tumor cells take advantage of immune checkpoints to evade immune responses, the relationships between the CSMD2 expression and the most common immune checkpoints, including TIGIT, CD274, PDCD1, LAG3, HAVCR2, CTLA4, IDO1, and PDCD1LG2 was also analyzed.